Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-25-022761
Filing Date
2025-05-06
Accepted
2025-05-06 17:04:29
Documents
86
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q dna-20250331.htm   iXBRL 10-Q 1114150
2 EX-10.1 dna-20250331xex101.htm EX-10.1 102955
3 EX-10.2 dna-20250331xex102.htm EX-10.2 123132
4 EX-31.1 dna-20250331xex311.htm EX-31.1 11785
5 EX-31.2 dna-20250331xex312.htm EX-31.2 11802
6 EX-32.1 dna-20250331xex321.htm EX-32.1 5892
7 EX-32.2 dna-20250331xex322.htm EX-32.2 6004
  Complete submission text file 0001628280-25-022761.txt   8017243

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dna-20250331.xsd EX-101.SCH 60532
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT dna-20250331_cal.xml EX-101.CAL 74206
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dna-20250331_def.xml EX-101.DEF 435938
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dna-20250331_lab.xml EX-101.LAB 694974
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dna-20250331_pre.xml EX-101.PRE 591170
89 EXTRACTED XBRL INSTANCE DOCUMENT dna-20250331_htm.xml XML 1008944
Mailing Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210
Business Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210 (877) 442-5362
Ginkgo Bioworks Holdings, Inc. (Filer) CIK: 0001830214 (see all company filings)

EIN.: 872652913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40097 | Film No.: 25918189
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)